International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Title:
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Author:
Dombret, Hervé Seymour, John F. Butrym, Aleksandra Wierzbowska, Agnieszka Selleslag, Dominik Jang, Jun Ho Kumar, Rajat Cavenagh, James Schuh, Andre C. Candoni, Anna Récher, Christian Sandhu, Irwindeep Bernal del Castillo, Teresa Al-Ali, Haifa Kathrin Martinelli, Giovanni Falantes, Jose Noppeney, Richard Stone, Richard M. Minden, Mark D. McIntyre, Heidi Songer, Steve Lucy, Lela M. Beach, C.L. Döhner, Hartmut